Chinese Medicine Treatment for Afatinib-Induced Paronychia

Pei-Yuu Yang; Chen-Jei Tai

doi:10.1155/2017/7327359

Chinese Medicine Treatment for Afatinib-Induced Paronychia

Research output: Contribution to journal › Article › peer-review

Abstract

Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.

Original language	English
Pages (from-to)	7327359
Journal	Case Reports in Oncological Medicine
Volume	2017
DOIs	https://doi.org/10.1155/2017/7327359
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1155/2017/7327359

Cite this

@article{1a0cc2bdbc524f3fa5406ad36796b99d,

title = "Chinese Medicine Treatment for Afatinib-Induced Paronychia",

abstract = "Afatinib (Gilotrif{\texttrademark}) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.",

author = "Pei-Yuu Yang and Chen-Jei Tai",

year = "2017",

doi = "10.1155/2017/7327359",

language = "English",

volume = "2017",

pages = "7327359",

journal = "Case Reports in Oncological Medicine",

issn = "2090-6706",

publisher = "Hindawi Limited",

}

TY - JOUR

T1 - Chinese Medicine Treatment for Afatinib-Induced Paronychia

AU - Yang, Pei-Yuu

AU - Tai, Chen-Jei

PY - 2017

Y1 - 2017

N2 - Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.

AB - Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.

U2 - 10.1155/2017/7327359

DO - 10.1155/2017/7327359

M3 - Article

C2 - 28948057

SN - 2090-6706

VL - 2017

SP - 7327359

JO - Case Reports in Oncological Medicine

JF - Case Reports in Oncological Medicine

ER -

Chinese Medicine Treatment for Afatinib-Induced Paronychia

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this